Current Development of Therapeutic Vaccines in Lung Cancer

Vaccines, Journal Year: 2025, Volume and Issue: 13(2), P. 185 - 185

Published: Feb. 14, 2025

Cancer vaccines have a potential to change the current landscape of immunotherapy research and development. They target neutralize specific tumor cells by utilizing body's own immune system which offers promising modality in treating various cancers including lung cancer. Historically, prior vaccination approaches specifically towards cancer posed several challenges but also with early phase I/II trials showing improved overall survival. With better understanding as well advancements vaccine development, use both non-small cell (NSCLC) small (SCLC) has shown promise setting advanced stage cancers, resistance mechanisms, evasion, heterogeneity. The proposed solution is enroll patients stages disease, rather than waiting until progression occurs. Additionally, future efforts will focus on targeted identification novel neo-antigens. This review discussion analysis completed ongoing different strategies for development relation faced.

Language: Английский

---

At the cusp of a cure in Myeloma: Insights into pathogenesis, modeling and therapeutics

Seminars in Hematology, Journal Year: 2025, Volume and Issue: 62(1), P. 1 - 2

Published: Feb. 1, 2025

Language: Английский

---

Exploring the clinical trials, regulatory insights, and challenges of PROTACs in oncology

Seminars in Oncology, Journal Year: 2025, Volume and Issue: 52(2), P. 152339 - 152339

Published: April 1, 2025

Language: Английский

---

Melanoma Antigen Genes (MAGE); novel functional targets in Multiple Myeloma

Seminars in Hematology, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

---